Connect with us

Hi, what are you looking for?

POZ

Ending HIV requires addressing ‘everyday’ discrimination – study

In a study of 484 sexual minority men, the researchers found a strong correlation between discrimination and delayed HIV testing. Everyday discrimination – perceived bias based on race, ethnicity or sexual orientation during day-to-day life – may be one reason why this is occurring, they said.

Photo by Ryan Crisman from Unsplash.com

Sexual minority men who experience racial, ethnic and sexual prejudice are more likely to delay HIV testing, complicating efforts to end the more than 40-year epidemic.

This is according to a study – “Everyday Discrimination and HIV Testing Among Partnered Latino/x Sexual Minority Men in the United States: A Stratified Analysis by Birth Location” by Yong Gun Lee, Edward J. Alessi, Matthew Lynn, Tyrel J. Starks and Gabriel Robles – that appeared in AIDS Education and Prevention.

In parts of the world, the total HIV infection rates are stabilizing, noted Robles. But “what’s bad is that the trend for some subgroups, including some… sexual minority men, is going in the opposite direction.”

In a study of 484 sexual minority men, the researchers found a strong correlation between discrimination and delayed HIV testing. Everyday discrimination – perceived bias based on race, ethnicity or sexual orientation during day-to-day life – may be one reason why this is occurring, they said.

To end the HIV epidemic, a goal health authorities believe is possible by 2030early detection is essential. But for some of the most vulnerable populations, testing frequency is falling far short of what’s needed. Delays in testing can increase the likelihood of transmission for those unaware of their HIV status.

“We have the technology to stop this epidemic; it’s things like this that are going to get in the way,” said Robles. “How can we bring the available medical technology to communities that need it? Only when we navigate psychosocial barriers will 2030 begin to look like a realistic goal.”

Advertisement
Advertisement

Like Us On Facebook

YOU MAY ALSO LIKE

POZ

Long-acting HIV therapies are becoming an increasingly competitive treatment category. While efficacy remains essential, differentiation is now shifting towards factors such as dosing convenience,...

POZ

A one-time regimen of therapies given to newborns within three days of birth may permanently clear the virus.

POZ

Although modern medicines have transformed HIV into a manageable long-term condition, taking medication every day can still contribute to stigma and treatment fatigue for...

POZ

Although new HIV infections and AIDS-related deaths are at their lowest levels in more than 30 years, the current HIV response is extremely fragile.

Advertisement